Symtuza

Symtuza is a prescription antiretroviral medication combining emtricitabine, tenofovir alafenamide, darunavir, and cobicistat for oral use. It is used in HIV treatment regimens to support viral suppression. This once-daily tablet is designed for adults and adolescents living with HIV.

Symtuza is used to treat HIV-1 infection in adults and adolescents weighing at least 40 kg. It combines four active ingredients to reduce the amount of virus in the body and maintain immune function. This medication is part of antiretroviral therapy (ART) and is not a cure for HIV. It is prescribed to help manage chronic HIV infection.

Symtuza works by interfering with the virus’s ability to multiply, which helps reduce the viral load over time. Patients may notice improved energy levels and general well-being as the medication takes effect. Regular use as prescribed is important to maintain its benefits. Individual responses may vary based on health and treatment history.

Symtuza should be taken exactly as prescribed by a healthcare provider. It is important to attend regular medical appointments to monitor treatment progress and check for side effects. Patients should inform their doctor about all current medications and health conditions before starting Symtuza. Keep this medication out of reach of children.

Symtuza can interact with other medications, including those metabolized by the liver or affecting kidney function. Common interaction classes include certain antibiotics, antifungals, cholesterol medications, and herbal supplements like St. John’s Wort. Alcohol and grapefruit products may also interact with Symtuza. Always consult a healthcare provider before combining medications.